Clexio Biosci 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CLE-100 / Clexio Biosci
SOLEO, NCT06340958: A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

Active, not recruiting
2
90
US
CLE-100, Placebo
Clexio Biosciences Ltd.
Adjunctive Treatment of Major Depressive Disorder (MDD)
07/25
01/26
CLE-500 / Clexio Biosci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CLE-100 / Clexio Biosci
SOLEO, NCT06340958: A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

Active, not recruiting
2
90
US
CLE-100, Placebo
Clexio Biosciences Ltd.
Adjunctive Treatment of Major Depressive Disorder (MDD)
07/25
01/26
CLE-500 / Clexio Biosci
No trials found

Download Options